Weight loss pen worth millions
On Japanese hand-carried goods websites, Spcell GLP-1 Semaglutide pens are widely sold. Sellers introduce this as an injectable drug that can support weight loss in obese people; treat type 2 diabetes, reduce the risk of major cardiovascular events such as stroke, myocardial infarction thanks to the ability to "increase the feeling of fullness for a long time, increase insulin production, reduce atherosclerosis".
Livestream image advertising Japanese weight loss injections.
For example, on the Facebook page "BNCC", the Japanese weight loss pen is introduced as the most effective and gentle weight loss drug "with only 1 injection/week and injected for 6 weeks for visible weight loss results, without the need for exercise. Quickly order and use to have a beautiful body". The livestream received the attention of hundreds of customers.
The price of the above pen sold on the market ranges from 3.8 - 4.3 million VND/pen.
Ms. Nguyen Trang Phuong (Hanoi) said: "I saw that they introduced it so well, effective weight loss but gentle, just with a tiny injection in the abdomen, so I also wanted to try it.
However, I am worried about whether this weight loss method is sustainable; this type of injection pen is used for diabetic patients, so will using it to lose weight affect health? Does it require a doctor's prescription or is it contraindicated for any subjects or diseases?
Not licensed in Vietnam
Dr. Lam Van Hoang, Head of the Department of Endocrinology - Diabetes, Tam Anh General Hospital, Ho Chi Minh City, said that Spcell GLP-1 is a diabetes drug, studied on diabetics and showed effectiveness in reducing blood sugar. At the same time, it is effective for weight loss, this has been studied on a population without diabetes and showed positive weight loss effects.
Advertisements for weight loss injections appear frequently on Japanese hand-carried goods websites.
Therefore, the drug has been approved by the US Food and Drug Administration (FDA) and obesity organizations around the world as a weight loss treatment. However, this is a drug that has not been approved for use in Vietnam, so people need to consider it.
Currently, some countries such as Canada, Australia, and some countries in Asia... have warned about the quality of drugs floating on the market.
According to a medical expert, in 2021, the FDA approved the injectable diabetes drug Semaglutide to treat overweight people, opening up an effective treatment option for overweight patients with a BMI over 27. This drug treats diabetes by increasing the amount of insulin in the body after each meal.
GLP-1 has a short lifespan in the body, only a few minutes, before being neutralized by other enzymes. GLP1 drugs that are modified to resist the enzyme last longer, about a few hours, stimulating the body to produce more insulin to lower blood sugar levels.
Do not self-treat obesity.
The expert added that the way GLP1 helps lose weight is not only based on treating diabetes but mainly on the effect of this drug on the brain. The receptors of the feeling of fullness in the brain will receive signals from this drug. Therefore, the user will feel full, have less appetite and no longer want to eat, leading to weight loss.
Meanwhile, Dr. Hoang emphasized that not everyone can lose weight the same way, simply because each person's body absorbs food and metabolizes nutrients differently depending on gender, age, and genetics. Some people eat 100 grams of fat and absorb 50 grams, while others eat the same 100 grams of fat and only absorb 10 grams.
Because of the different absorption amounts, the risk of weight gain is different. Some people only need 1 day to excrete food while others need 2 days. Therefore, the time the amount of food stays in the digestive system is different, leading to different absorption.
"Underlying diseases will also affect different nutritional absorption regimens. For example, diabetes will increase the risk of being overweight and make it easier to absorb fat into the blood... Therefore, all drugs to treat obesity must be prescribed by a doctor, because obesity has many causes," said Dr. Hoang.
Side effects warning
According to doctors, common side effects of GLP1 drugs are vomiting, diarrhea, nausea, abdominal pain, stomach pain, hypoglycemia, gastritis or enteritis. The most dangerous is the increased risk of developing C-cell thyroid cancer (although very low) and acute pancreatitis.
(Pancreatitis). Therefore, the above drug should not be used in patients with a history of thyroid cancer or MEN2 endocrine cancer.
Source: https://www.baogiaothong.vn/can-trong-voi-but-tiem-giam-can-192241017221718914.htm
Comment (0)